![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 5
Zeitschriftenartikel
Westphalen, C.B. 
ORCID: https://orcid.org/0000-0002-5310-3754; Martins-Branco, D. ORCID: https://orcid.org/0000-0002-7214-4818; Beal, J.R. ORCID: https://orcid.org/0000-0001-8898-0549; Cardone, C.; Coleman, N.; Schram, A.M.; Halabi, S.; Michiels, S. ORCID: https://orcid.org/0000-0002-6963-2968; Yap, C. ORCID: https://orcid.org/0000-0002-6715-2514; André, F.; Bibeau, F.; Curigliano, G. ORCID: https://orcid.org/0000-0003-1781-2518; Garralda, E. ORCID: https://orcid.org/0000-0002-4412-7842; Kummar, S.; Kurzrock, R. ORCID: https://orcid.org/0000-0003-4110-1214; Limaye, S.; Loges, S.; Marabelle, A. ORCID: https://orcid.org/0000-0002-5816-3019; Marchió, C.; Mateo, J.; Rodon, J. ORCID: https://orcid.org/0000-0001-6467-3632; Spanic, T.; Pentheroudakis, G. ORCID: https://orcid.org/0000-0002-6632-2462 und Subbiah, V. ORCID: https://orcid.org/0000-0002-6064-6837
(2024):
The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development.
In: Annals of Oncology, Bd. 35, Nr. 11: S. 936-953
[PDF, 2MB]
ORCID: https://orcid.org/0000-0002-5310-3754; Martins-Branco, D. ORCID: https://orcid.org/0000-0002-7214-4818; Beal, J.R. ORCID: https://orcid.org/0000-0001-8898-0549; Cardone, C.; Coleman, N.; Schram, A.M.; Halabi, S.; Michiels, S. ORCID: https://orcid.org/0000-0002-6963-2968; Yap, C. ORCID: https://orcid.org/0000-0002-6715-2514; André, F.; Bibeau, F.; Curigliano, G. ORCID: https://orcid.org/0000-0003-1781-2518; Garralda, E. ORCID: https://orcid.org/0000-0002-4412-7842; Kummar, S.; Kurzrock, R. ORCID: https://orcid.org/0000-0003-4110-1214; Limaye, S.; Loges, S.; Marabelle, A. ORCID: https://orcid.org/0000-0002-5816-3019; Marchió, C.; Mateo, J.; Rodon, J. ORCID: https://orcid.org/0000-0001-6467-3632; Spanic, T.; Pentheroudakis, G. ORCID: https://orcid.org/0000-0002-6632-2462 und Subbiah, V. ORCID: https://orcid.org/0000-0002-6064-6837
(2024):
The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development.
In: Annals of Oncology, Bd. 35, Nr. 11: S. 936-953
[PDF, 2MB]
Trapani, D.; Franzoi, M. A.; Burstein, H. J.; Carey, L. A.; Delaloge, S.; Harbeck, N.; Hayes, D. F.; Kalinsky, K.; Pusztai, L.; Regan, M. M.; Sestak, I.; Spanic, T.; Sparano, J.; Jezdic, S.; Cherny, N.; Curigliano, G. und Andre, F.
(2022):
Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification.
In: Annals of Oncology, Bd. 33, Nr. 7: S. 702-712
Paluch-Shimon, S.; Cardoso, F.; Partridge, A. H.; Abulkhair, O.; Azim, H. A.; Bianchi-Micheli, G.; Cardoso, M. J.; Curigliano, G.; Gelmon, K. A.; Gentilini, O.; Harbeck, N.; Kaufman, B.; Kim, S. B.; Liu, Q.; Merschdorf, J.; Poortmans, P.; Pruneri, G.; Senkus, E.; Sirohi, B.; Spanic, T.; Sulosaari, V.; Peccatori, F. und Pagani, O.
(2022):
ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5).
In: Annals of Oncology, Bd. 33, Nr. 11: S. 1097-1118
Gennari, A.; Andre, F.; Barrios, C. H.; Cortes, J.; de Azambuja, E.; DeMichele, A.; Dent, R.; Fenlon, D.; Gligorov, J.; Hurvitz, S. A.; Im, S. -a.; Krug, D.; Kunz, W. G.; Loi, S.; Penault-Llorca, F.; Ricke, J.; Robson, M.; Rugo, H. S.; Saura, C.; Schmid, P.; Singer, C. F.; Spanic, T.; Tolaney, S. M.; Turner, N. C.; Curigliano, G.; Loibl, S.; Paluch-Shimon, S. und Harbeck, N.
(2021):
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer.
In: Annals of Oncology, Bd. 32, Nr. 12: S. 1475-1495
Paluch-Shimon, S.; Cardoso, F.; Partridge, A. H.; Abulkhair, O.; Azim, H. A.; Bianchi-Micheli, G.; Cardoso, M-J; Curigliano, G.; Gelmon, K. A.; Harbeck, N.; Merschdorf, J.; Poortmans, P.; Pruneri, G.; Senkus, E.; Spanic, T.; Stearns, V.; Wengstrom, Y.; Peccatori, F. und Pagani, O.
(2020):
ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4).
In: Annals of Oncology, Bd. 31, Nr. 6: S. 674-696